Supplementary Table S12 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET)

作者：Chibawanye Ene, Sanjay K. Singh, Thiagarajan Venkataraman, Lynette M. Phillips, James P. Long, Deep Singh, Nam Tran, Frank Tufaro, PJ Anand, Nicholas E. Navin, Sujit S. Prabhu, Jeffrey S. Weinberg, H. Benjamin Larman, Candelaria Gomez‐Manzano, Juàn Fueyo, Frederick F. Lang · 年份：2026 · DOI：10.1158/1078-0432.32714082 · 研究领域：Virus-based gene therapy research、Glioma Diagnosis and Treatment、Cancer Immunotherapy and Biomarkers

<p>Adverse events with incidence > 10% in Delta-24-RGD + IFN-γ cohort</p>